These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30151760)

  • 41. Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing.
    Chadwick AC; Musunuru K
    Curr Atheroscler Rep; 2017 Jul; 19(7):32. PubMed ID: 28550381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPR-GE: A Convenient Software Toolkit for CRISPR-Based Genome Editing.
    Xie X; Ma X; Zhu Q; Zeng D; Li G; Liu YG
    Mol Plant; 2017 Sep; 10(9):1246-1249. PubMed ID: 28624544
    [No Abstract]   [Full Text] [Related]  

  • 43. CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer.
    Selvakumar SC; Preethi KA; Ross K; Tusubira D; Khan MWA; Mani P; Rao TN; Sekar D
    Mol Cancer; 2022 Mar; 21(1):83. PubMed ID: 35331236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The CRISPR tool kit for genome editing and beyond.
    Adli M
    Nat Commun; 2018 May; 9(1):1911. PubMed ID: 29765029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome editing in the mammalian brain using the CRISPR-Cas system.
    Nishiyama J
    Neurosci Res; 2019 Apr; 141():4-12. PubMed ID: 30076877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heritable genome editing with CRISPR/Cas9 induces anosmia in a crop pest moth.
    Koutroumpa FA; Monsempes C; François MC; de Cian A; Royer C; Concordet JP; Jacquin-Joly E
    Sci Rep; 2016 Jul; 6():29620. PubMed ID: 27403935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient genome editing of wild strawberry genes, vector development and validation.
    Zhou J; Wang G; Liu Z
    Plant Biotechnol J; 2018 Nov; 16(11):1868-1877. PubMed ID: 29577545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A simple and practical workflow for genotyping of CRISPR-Cas9-based knockout phenotypes using multiplexed amplicon sequencing.
    Iida M; Suzuki M; Sakane Y; Nishide H; Uchiyama I; Yamamoto T; Suzuki KT; Fujii S
    Genes Cells; 2020 Jul; 25(7):498-509. PubMed ID: 32323394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CrispRVariants charts the mutation spectrum of genome engineering experiments.
    Lindsay H; Burger A; Biyong B; Felker A; Hess C; Zaugg J; Chiavacci E; Anders C; Jinek M; Mosimann C; Robinson MD
    Nat Biotechnol; 2016 Jul; 34(7):701-2. PubMed ID: 27404876
    [No Abstract]   [Full Text] [Related]  

  • 54. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
    Wang S; Dong S; Wang P; Tao Y; Wang Y
    Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
    [No Abstract]   [Full Text] [Related]  

  • 55. CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research.
    Wang D; Wang XW; Peng XC; Xiang Y; Song SB; Wang YY; Chen L; Xin VW; Lyu YN; Ji J; Ma ZW; Li CB; Xin HW
    Cancer Gene Ther; 2018 Jun; 25(5-6):93-105. PubMed ID: 29691470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
    Alagoz Y; Gurkok T; Zhang B; Unver T
    Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CRISPR-engineered genome editing for the next generation neurological disease modeling.
    Feng W; Liu HK; Kawauchi D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():459-467. PubMed ID: 28536069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CRISPR-GRANT: a cross-platform graphical analysis tool for high-throughput CRISPR-based genome editing evaluation.
    Fu H; Shan C; Kang F; Yu L; Li Z; Yin Y
    BMC Bioinformatics; 2023 May; 24(1):219. PubMed ID: 37254060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.